Screening for Iron Deficiency Anemia
Screen using hemoglobin (Hb) or hematocrit (Hct) measurement, with the specific approach determined by patient age, sex, and risk factors—universal screening is recommended for high-risk populations while selective screening based on risk assessment is appropriate for low-risk groups.
Screening Method
The practical screening test is Hb concentration or Hct measurement 1. While earlier markers of iron deficiency exist (erythrocyte protoporphyrin, serum ferritin), their cost, feasibility, and variability preclude routine screening use 1. Serum ferritin is the most specific confirmatory test when iron deficiency is suspected, but it is not the primary screening tool 2.
Population-Specific Screening Strategies
Infants and Young Children (0-5 years)
High-Risk Populations (Universal Screening)
Screen all children in these groups 1:
- Low-income families
- Children at or below poverty level
- Black or Mexican-American children
- WIC-eligible children
- Migrant or recently arrived refugee children
Timing:
- First screen: 9-12 months of age
- Second screen: 6 months later (15-18 months)
- Then annually from ages 2-5 years 1
Important caveat: Screening before 6 months is of little value in full-term, normal birthweight infants as their iron stores are adequate until this age 1.
Low-Risk Populations (Selective Screening)
Screen only children with specific risk factors 1:
- Preterm or low birthweight infants (consider screening before 6 months if not on iron-fortified formula)
- Non-iron-fortified formula use >2 months
- Cow's milk introduction before 12 months
- Cow's milk consumption >24 oz daily
- Breastfed infants with inadequate iron from complementary foods after 6 months
- Special health-care needs (medications interfering with iron absorption, chronic infection, inflammatory disorders, restricted diets, significant blood loss)
Adolescent Girls and Women of Childbearing Age
Periodic screening during routine medical examinations is indicated 1. This recommendation is based on:
- Most women have dietary iron intake below recommended levels
- ~10% experience heavy menstrual blood loss requiring iron above dietary allowance
- High prevalence of iron deficiency in this population 1
Pregnant Women
Screen at the first prenatal visit using Hb or Hct 1. The 2015 USPSTF guideline supports screening pregnant women 3. More recent evidence suggests screening with serum ferritin in the first trimester plus regular Hb checks at least once per trimester 4.
Anemia criteria in pregnancy:
- First trimester: Hb <11.0 g/dL or Hct <33.0%
- Second trimester: Hb <10.5 g/dL or Hct <32.0%
- Third trimester: Hb <11.0 g/dL or Hct <33.0%
Postpartum Women
Screen women at 4-6 weeks postpartum if risk factors present 1:
- Anemia continued through third trimester
- Excessive blood loss during delivery
- Multiple birth
Men and Postmenopausal Women
No routine screening recommended 1. Iron deficiency and IDA are uncommon in these populations, making screening not highly predictive. Any anemia detected incidentally should be fully evaluated for underlying cause, as it may indicate gastrointestinal pathology requiring investigation 2, 5.
Diagnostic Confirmation
When screening is positive:
- Repeat the Hb/Hct test to confirm 1
- If confirmed and patient not acutely ill, presume iron deficiency anemia
- Serum ferritin <15 μg/L is highly specific for iron deficiency (specificity 0.99) 2
- Serum ferritin <45 μg/L provides good specificity (0.92) and may warrant investigation, especially with chronic inflammation 2
- Consider Hb electrophoresis in microcytic patients with normal iron studies, particularly with appropriate ethnic background, to exclude thalassemia 2
Key Clinical Pitfalls
- Don't screen too early: Full-term infants with normal birthweight don't need screening before 6 months 1
- Risk-stratify appropriately: In populations with <10% iron deficiency prevalence, universal screening has poor positive predictive value—use selective screening instead 1
- Ferritin interpretation in inflammation: Serum ferritin is an acute phase reactant; apparently normal levels may mask iron deficiency in inflammatory conditions. Use higher cutoffs (up to 45 μg/L) in these contexts 2
- Don't ignore non-anemic iron deficiency: While this guideline focuses on anemia screening, recognize that iron deficiency exists before anemia develops, particularly relevant in premenopausal women with menorrhagia 2
The evidence base for these recommendations comes primarily from CDC guidelines [1-1], with more recent supporting evidence from specialty society guidelines [3-5]. The 1998 CDC recommendations remain the most comprehensive screening framework, though they predate some newer diagnostic markers.